Articles

Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors

Department of Immunotechnology, Lund University
Department of Immunotechnology, Lund University
Department of Hematology, Rigshospitalet, Copenhagen
Department of Hematology, Rigshospitalet, Copenhagen
Department of Hematology, Rigshospitalet, Copenhagen
Department of Hematology, Helsinki University Hospital, Helsinki
Department of Oncology, Oslo University Hospital, Oslo
Department of Hematology, Rigshospitalet, Copenhagen
Department of Clinical Sciences, Oncology and Pathology, Lund University, Lund
Department of Oncology, Lund University Hospital, Lund
Department of Immunotechnology, Lund University
Haematologica Early view Dec 15, 2022 https://doi.org/10.3324/haematol.2022.281420